Cargando…

Utility of surveillance blood cultures in patients undergoing hematopoietic stem cell transplantation

BACKGROUND: Surveillance blood cultures are often obtained in hematopoietic stem cell transplant (HSCT) patients for detection of bloodstream infection. The major aims of this retrospective cohort study were to determine the utility of the practice of obtaining surveillance blood cultures from asymp...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghazal, Sameeh S, Stevens, Michael P, Bearman, Gonzalo M, Edmond, Michael B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082284/
https://www.ncbi.nlm.nih.gov/pubmed/24999384
http://dx.doi.org/10.1186/2047-2994-3-20
_version_ 1782324238166786048
author Ghazal, Sameeh S
Stevens, Michael P
Bearman, Gonzalo M
Edmond, Michael B
author_facet Ghazal, Sameeh S
Stevens, Michael P
Bearman, Gonzalo M
Edmond, Michael B
author_sort Ghazal, Sameeh S
collection PubMed
description BACKGROUND: Surveillance blood cultures are often obtained in hematopoietic stem cell transplant (HSCT) patients for detection of bloodstream infection. The major aims of this retrospective cohort study were to determine the utility of the practice of obtaining surveillance blood cultures from asymptomatic patients during the first 100 post-transplant days and to determine if obtaining more than one positive blood culture helps in the diagnosis of bloodstream infection. METHODS: We conducted a 17-month retrospective analysis of all blood cultures obtained for patients admitted to the hospital for HSCT from January 2010 to June 2011. Each patient’s clinical course, vital signs, diagnostic testing, treatment, and response to treatment were reviewed. The association between number of positive blood cultures and the final diagnosis was analyzed. RESULTS: Blood culture results for 205 patients were reviewed. Cultures obtained when symptoms of infection were present (clinical cultures) accounted for 1,033 culture sets, whereas 2,474 culture sets were classified as surveillance cultures (no symptoms of infection were present). The total number of positive blood cultures was 185 sets (5.3% of cultures obtained) and accounted for 84 positive culture episodes. Incidence of infection in autologous, related allogeneic and unrelated allogeneic transplants was 8.3%, 20.0%, and 28.6% respectively. Coagulase-negative staphylococci were the most common organisms isolated. Based on our application of predefined criteria there were 29 infections and 55 episodes of positive blood cultures that were not infections. None of the patients who developed infection were diagnosed by surveillance blood cultures. None of the uninfected patients with positive blood cultures showed any clinical changes after receiving antibiotics. There was a significant difference between the incidence of BSI in the first and second 50-day periods post-HSCT. There was no association between the number of positive blood cultures and the final diagnosis. CONCLUSION: Surveillance blood cultures in patients who have undergone HSCT do not identify bloodstream infections. The number of positive blood cultures was not helpful in determining which patients had infection. Patients are at higher risk of infection in the first 50 days post-transplant period.
format Online
Article
Text
id pubmed-4082284
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40822842014-07-05 Utility of surveillance blood cultures in patients undergoing hematopoietic stem cell transplantation Ghazal, Sameeh S Stevens, Michael P Bearman, Gonzalo M Edmond, Michael B Antimicrob Resist Infect Control Research BACKGROUND: Surveillance blood cultures are often obtained in hematopoietic stem cell transplant (HSCT) patients for detection of bloodstream infection. The major aims of this retrospective cohort study were to determine the utility of the practice of obtaining surveillance blood cultures from asymptomatic patients during the first 100 post-transplant days and to determine if obtaining more than one positive blood culture helps in the diagnosis of bloodstream infection. METHODS: We conducted a 17-month retrospective analysis of all blood cultures obtained for patients admitted to the hospital for HSCT from January 2010 to June 2011. Each patient’s clinical course, vital signs, diagnostic testing, treatment, and response to treatment were reviewed. The association between number of positive blood cultures and the final diagnosis was analyzed. RESULTS: Blood culture results for 205 patients were reviewed. Cultures obtained when symptoms of infection were present (clinical cultures) accounted for 1,033 culture sets, whereas 2,474 culture sets were classified as surveillance cultures (no symptoms of infection were present). The total number of positive blood cultures was 185 sets (5.3% of cultures obtained) and accounted for 84 positive culture episodes. Incidence of infection in autologous, related allogeneic and unrelated allogeneic transplants was 8.3%, 20.0%, and 28.6% respectively. Coagulase-negative staphylococci were the most common organisms isolated. Based on our application of predefined criteria there were 29 infections and 55 episodes of positive blood cultures that were not infections. None of the patients who developed infection were diagnosed by surveillance blood cultures. None of the uninfected patients with positive blood cultures showed any clinical changes after receiving antibiotics. There was a significant difference between the incidence of BSI in the first and second 50-day periods post-HSCT. There was no association between the number of positive blood cultures and the final diagnosis. CONCLUSION: Surveillance blood cultures in patients who have undergone HSCT do not identify bloodstream infections. The number of positive blood cultures was not helpful in determining which patients had infection. Patients are at higher risk of infection in the first 50 days post-transplant period. BioMed Central 2014-06-04 /pmc/articles/PMC4082284/ /pubmed/24999384 http://dx.doi.org/10.1186/2047-2994-3-20 Text en Copyright © 2014 Ghazal et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ghazal, Sameeh S
Stevens, Michael P
Bearman, Gonzalo M
Edmond, Michael B
Utility of surveillance blood cultures in patients undergoing hematopoietic stem cell transplantation
title Utility of surveillance blood cultures in patients undergoing hematopoietic stem cell transplantation
title_full Utility of surveillance blood cultures in patients undergoing hematopoietic stem cell transplantation
title_fullStr Utility of surveillance blood cultures in patients undergoing hematopoietic stem cell transplantation
title_full_unstemmed Utility of surveillance blood cultures in patients undergoing hematopoietic stem cell transplantation
title_short Utility of surveillance blood cultures in patients undergoing hematopoietic stem cell transplantation
title_sort utility of surveillance blood cultures in patients undergoing hematopoietic stem cell transplantation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082284/
https://www.ncbi.nlm.nih.gov/pubmed/24999384
http://dx.doi.org/10.1186/2047-2994-3-20
work_keys_str_mv AT ghazalsameehs utilityofsurveillancebloodculturesinpatientsundergoinghematopoieticstemcelltransplantation
AT stevensmichaelp utilityofsurveillancebloodculturesinpatientsundergoinghematopoieticstemcelltransplantation
AT bearmangonzalom utilityofsurveillancebloodculturesinpatientsundergoinghematopoieticstemcelltransplantation
AT edmondmichaelb utilityofsurveillancebloodculturesinpatientsundergoinghematopoieticstemcelltransplantation